Impact of age on the quality of care in endometrial cancer: a retrospective study of 145 patients

Objectives: Endometrial cancer is the fourth most common cancer and affects mostly the elderly. Advanced age is a poor prognostic factor but reasons are numerous and controversial. The objective of this study was to characterize the effect of age on endometrial cancer patients medical care. Materials and Methods: It was a descriptive and comparative study of a retrospective cohort of 145 patients having received care for endometrial cancer during ten years in the Gynecological Department of Saint-Etienne Hospital. The 145 patients studied were subdivided into three groups according to their age at diagnosis: < 70 (group 1), 70-79 (group 2), and > 80 (group 3). The data collected were: clinical characteristics; preoperative, operating and pathological data, and postoperative care. For each patient, the authors evaluated compliance to patient management guidelines. Results: Postmenopausal bleeding was the most common reason of first consultation and incidental diagnoses were more frequent in group 2 (13.8%). Concerning FIGO staging, there was an over-representation of Stages III and IV in group 1, while the distribution was more in favor of Stages I and II for older patients groups. No para-aortic lymphadenectomy was performed in patients from group 3 despite seven theoretical indications. This non-compliance to guidelines was detected in two-thirds of patients in group 3. Conclusion: Elderly patients from the present cohort showed less aggressive and advanced tumors compared to younger patients. Yet, they did not receive optimal surgical and adjuvant therapy according to guidelines. A multidisciplinary evaluation using standardized assessment is needed in order to help physicians in the decision-making process.

Elderly patients; Gynecologic oncology; Endometrial cancer.

[1] Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A.: “Global cancer statistics, 2012”. CA Cancer J. Clin., 2015, 65, 87.

[2] Yancik R., Ries L.A.G.: “Cancer in older persons: an international issue in an aging world”. Semin. Oncol., 2004, 31, 128.

[3] Kosary C.L.: “FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina”. Semin. Surg. Oncol., 1994, 10, 31.

[4] Zaino R.J., Kurman R.J., Diana K.L., Morrow C.P.: “Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage—a Gynecologic Oncology Group study”. Cancer, 1996, 77, 1115.

[5] Ahmed A., Zamba G., DeGeest K., Lynch C.F.: “The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002”. Gynecol Oncol., 2008, 111, 35.

[6] Alektiar K.M., Venkatraman E., Abu-Rustum N., Barakat R.R.: “Is endometrial carcinoma intrinsically more aggressive in elderly patients?” Cancer, 2003, 98, 2368.

[7] Farley J.H., Nycum L.R., Birrer M.J., Park R.C., Taylor R.R.: “Agespecific survival of women with endometrioid adenocarcinoma of the uterus”. Gynecol Oncol., 2000, 79, 86.

[8] Lee E-J., Kim T-J., Choi C.H., Lee J-W., Lee J-H., Bae D-S., et al.: Uterine endometrial carcinoma: 10 years’ experience with long-term follow-up at a single Korean institution”. Gynecol. Obstet. Invest., 2012, 74, 313.

[9] Labastida R., Dexeus S., Fábregas R., Tresserra F., Fernández A.: “Endometrial cancer: factors affecting survival”. Eur. J. Gynaecol. Oncol., 2003, 24, 381.

[10] Truong P.T., Kader H.A., Lacy B., Lesperance M., MacNeil M.V., Berthelet E., et al.: “The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer”. Am. J. Clin. Oncol., 2005, 28, 157.

[11] Ouldamer L., Duquesne M., Arbion F., Barillot I., Marret H., Body G.: “The impact of therapeutic management on survival of elderly women with endometrial cancer”. Gynecol. Obstet. Fertil., 2012, 40, 759. [Article in French]

[12] Okuma K., Yamashita H., Kawana K., Nakagawa S., Oda K., Nakagawa K.: “Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer”. J. Obstet. Gynaecol. Res., 2010, 36, 757.

[13] Fleming N.D., Lentz S.E., Cass I., Li A.J., Karlan B.Y., Walsh C.S.: “Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?” Gynecol. Oncol., 2011, 120, 189.

[14] Bittoni M.A., Fisher J.L., Fowler J.M., Maxwell G.L., Paskett E.D.: “Assessment of the effects of severe obesity and lifestyle risk factors on stage of endometrial cancer”. Cancer Epidemiol. Biomark. Prev., 2013, 22, 76.

[15] Setiawan V.W., Yang H.P., Pike M.C., McCann S.E., Yu H., Xiang YB., et al.: “Type I and II endometrial cancers: have they different risk factors?” J. Clin. Oncol., 2013, 31, 2607.

[16] Luber K.M., Boero S., Choe J.Y.: “The demographics of pelvic floor disorders: current observations and future projections”. Am. J. Obstet. Gynecol., 2001, 184, 1496.

[17] Denschlag D., Ulrich U., Emons G.: “The diagnosis and treatment of endometrial cancer: progress and controversies”. Dtsch. Ärztebl. Int., 2010, 108, 571.

[18] Kumar S., Shah J.P., Bryant C.S., Seward S., Ali-Fehmi R., Morris R.T., et al.: “Radiation-associated endometrial cancer”. Obstet. Gynecol., 2009, 113, 319.

[19] Gayar O.H., Robbins J.R., Parikh K., Lu M., Buekers T., Munkarah A., et al.: “Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome”. Gynecol. Oncol., 2011, 123, 71.

[20] Lachance J.A., Everett E.N., Greer B., Mandel L., Swisher E., Tamimi H., et al.: “The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer”. Gynecol. Oncol., 2006, 101, 470.

[21] Lindahl B., Ranstam J., Willén R.: “Five year survival rate in endometrial carcinoma stages I—II: influence of degree of tumour differentiation, age, myometrial invasion and DNA content”. Br. J. Obstet. Gynaecol., 1994, 101, 621.

[22] Coronado P.J., Herraiz M.A., Magrina J.F., Fasero M., Vidart J.A.: “Comparison of perioperative outcomes and cost of robotic-assisted laparoscopy, laparoscopy and laparotomy for endometrial cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2012, 165, 289.

[23] Santi A., Kuhn A., Gyr T., Eberhard M., Johann S., Günthert A.R., et al.: “Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer”. Surg. Endosc., 2010, 24, 939.

[24] Hauspy J., Jiménez W., Rosen B., Gotlieb W.H., Fung-Kee-Fung M., Plante M.: “Laparoscopic surgery for endometrial cancer: a review”. J. Obstet. Gynaecol. Can., 2010, 32, 570.

[25] Leitao M.M.: “Current and future surgical approaches in the management of endometrial carcinoma”. Future Oncol. Lond. Engl., 2008, 4, 389.

[26] Walker J.L., Piedmonte M.R., Spirtos N.M., Eisenkop S.M., Schlaerth J.B., Mannel R.S., et al.: “Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2”. J. Clin. Oncol., 2009, 27, 5331.

[27] Malinowski A., Majchrzak-Baczmańska D., Pogoda K., Maciołek- Blewniewska G., Antosiak B.: “Evaluation of total laparoscopic hysterectomy with lymphadenectomy in surgical treatment of endometrial cancers”. Ginekol. Pol., 2013, 84, 197.

[28] Huang C-Y., Ho C-M., Chen Y-L., You S-L., Chen C-A., Cheng WF.: “Impact of lymphadenectomy in uterine endometrioid carcinoma”. Eur. J. Surg. Oncol., 2013, 39, 350.

[29] O’Hanlan K.A., Pinto R.A., O’Holleran M.: “Total laparoscopic hysterectomy with and without lymph node dissection for uterine neoplasia”. J. Minim. Invasive Gynecol., 2007, 14, 449.

[30] Cormier B., Sauthier P., Lussier C., Zang G., Mayrand M-H.: “Determinants of lymph node count in endometrial cancer surgical staging”. Int. J. Gynecol. Cancer, 2012, 22, 1361.

[31] Aletti G.D., Dowdy S.C., Podratz K.C., Cliby W.A.: “Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer”. Am. J. Obstet. Gynecol., 2007, 197, 676.e1.

[32] Nout R.A., van de Poll-Franse L.V., Lybeert M.L.M., Wárlám-Rodenhuis C.C., Jobsen J.J., Mens J.W.M., et al.: “Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial”. J. Clin. Oncol., 2011, 29, 1692.

[33] Perri T., Katz T., Korach J., Beiner M.E., Jakobson-Setton A., Ben- Baruch G.: “Treating gynecologic malignancies in elderly patients”. Am. J. Clin. Oncol., 2015, 38, 278.

[34] Balducci L., Extermann M.: “Management of cancer in the older person: a practical approach”. Oncologist, 2000, 5, 224.

[35] Pope D., Ramesh H., Gennari R., Corsini G., Maffezzini M., Hoekstra H.J., et al.: “Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery”. Surg. Oncol., 2006, 15, 189